When it comes to the desert Southwest, it doesn't get more fitting than this iconic decades-old Arizona snack that's actually ...

The adventurer started this challenge to raise awareness and collect funds for Motor Neuron Disease in honour of his late father. The 51-year-old has crossed five continents to connect people with ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the industry. Please send the good word—or the bad—from your shop to Darren ...

Revenue: €75.0m (up 20% from 1Q 2024). Net loss: €154.6m (down from €23.5m profit in 1Q 2024). €2.35 loss per share (down from €0.36 profit in 1Q 2024). We've found 21 US stocks that are ...

Galapagos aims to achieve milestones such as the presentation of top-line data from the MCL cohort in the second half of 2025 and alignment with regulatory authorities for pivotal trial design.

Good day! And thank you for standing by. Welcome to the Galapagos First Quarter 2025 Financial Results and Business Update. At this time all participants are in a listener-only mode. After the ...

Mechelen, Belgium; April 23, 2025, 22:01 CET; regulated information - Galapagos NV (Euronext & Nasdaq: GLPG), a global biotechnology company dedicated to transforming patient outcomes through ...

Look, I understand the lure of Galapagos with all those exotic animals and the opportunity to say "blue footed booby". And while I have nothing against boobies, I'm not sure I'd travel all the way ...

Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...